Epithelial Mesenchymal Transition Top Journals
Epithelial–mesenchymal transition (EMT) may be a cellular programme that's known to be crucial for embryogenesis, wound healing and malignant progression. During EMT, cell–cell and cell–extracellular matrix interactions are remodelled, which results in the detachment of epithelial
cells from one another and therefore the underlying basement membrane, In the context of neoplasias, EMT confers on
cancer cells increased tumour-initiating and metastatic potential and a greater resistance to
elimination by several therapeutic regimens. In this Review, we discuss recent findings on the mechanisms and roles of EMT in normal and neoplastic tissues, and the cell-intrinsic signals that sustain expression of this programme. We also highlight how EMT gives rise to a variety of intermediate cell states between the epithelial and the mesenchymal state, which could function as
cancer stem cells. In addition, we describe the contributions of the tumour microenvironment in inducing EMT and the effects of EMT on the immunobiology of carcinomas. Epithelial–mesenchymal transition (EMT) may be a cellular mechanism long recognized as a central feature of normal development. Several developmental milestones, including gastrulation, neural crest formation and heart morphogenesis, believe the plastic transition between epithelium and mesenchyme
High Impact List of Articles
-
News: Effectiveness of Tamiflu during swine flu pandemic assessed
News and Views: Clinical Investigation
-
News: Effectiveness of Tamiflu during swine flu pandemic assessed
News and Views: Clinical Investigation
-
Boceprevir in the treatment of hepatitis C infection: rationale and clinical data
Omer Khalid ,Bruce R Bacon
Review Article: Clinical Investigation
-
Boceprevir in the treatment of hepatitis C infection: rationale and clinical data
Omer Khalid ,Bruce R Bacon
Review Article: Clinical Investigation
-
Drug-eluting balloons: where are we and what are the problems?
Beatrix Schnorr, Ulrich Speck, Bruno Scheller
Editorial: Clinical Investigation
-
Drug-eluting balloons: where are we and what are the problems?
Beatrix Schnorr, Ulrich Speck, Bruno Scheller
Editorial: Clinical Investigation
-
Developing an international network for clinical research: the European and Developing Countries Clinical Trials Partnership experience
Charles Mgone, Michael Makanga, Thomas Nyirenda
Clinical Trail Outcomes: Clinical Investigation
-
Developing an international network for clinical research: the European and Developing Countries Clinical Trials Partnership experience
Charles Mgone, Michael Makanga, Thomas Nyirenda
Clinical Trail Outcomes: Clinical Investigation
-
Tyrosine kinase inhibitors in differentiated thyroid arcinoma: a review of the clinical evidence
Hendrieke C Hoftijzer, Ellen Kapiteijn2, Tatiana, Schneider, Guido C Hovens, Hans Morreau, Hans Gelderblom, Johannes WA Smit
Review Article: Clinical Investigation
-
Tyrosine kinase inhibitors in differentiated thyroid arcinoma: a review of the clinical evidence
Hendrieke C Hoftijzer, Ellen Kapiteijn2, Tatiana, Schneider, Guido C Hovens, Hans Morreau, Hans Gelderblom, Johannes WA Smit
Review Article: Clinical Investigation
Relevant Topics in Clinical